期刊文献+

酰基保护的4-氨基-3,4-二氢-1(2H)-萘酮的立体选择性还原反应

The Stereoselective Reduction of Acyl Protected 4-Amino-3,4-dihydro-1(2H)-naphthalenone
下载PDF
导出
摘要 1,2,3,4-四氢-1-萘胺及其衍生物是一类重要的药物合成中间体.从光学纯的(R)-和(S)-1,2,3,4-四氢-1-萘胺出发,首先经乙酰化、苯甲酰化和邻苯二甲酰化反应制备相应酰胺,然后在高锰酸钾作用下氧化生成了氨基萘酮衍生物,收率为65%~85%.这些不同酰基保护的氨基萘酮衍生物经硼氢化钠(NaBH4)和二异丁基氢化铝(DIBAL-H)还原后得到两种构型的氨基萘醇混合产物,经二维核磁共振氢谱的核磁欧沃豪斯效应(NOE)推断,此还原反应的主产物是顺式构型的氨基萘醇,当(R)-或(S)-邻苯二甲酰化的氨基萘酮经DIBAL-H还原后主产物为顺式的氨基萘醇4ca和7ba,其非对映异构体过量(de)百分比分别为92.6%和98.2%. 1,2,3,4-Tetrahydronaphthalen-l-amine and its derivative were a series of important synthetic intermediates for bioactive compounds. Acylation of optically pure (R) - and (S) - 1, 2, 3, 4 - tetrahydronaphthalen-l-amine with acetic anhydride, benzoyl chloride and phthalic anhydride followed by oxidation with potassium permanganate to give acylated aminonaphthyl ketones in yields of 65% 85%. These aminonaphthyl ketones were reduced stereoselectively by sodium borohydride(NaBH4) or diisobutylaluminium hydride(DIBAL-H) to afford the aminonaphthyl alcohols mainly in cis-form, which was confirmed by nuclear Overhauser effect(NOE) obtained by 2D 1H NMR. When (R)-and (S)- phthalic protected aminonaphthyl ketone was reduced with DIBAL-H, cis-aminonaphthyl alcohols 4ca and 7ba were obtained as major product in diastereomeric excesses'(de) percentages of 92.6% and 98.2%, respectively.
出处 《东华大学学报(自然科学版)》 CAS CSCD 北大核心 2013年第1期70-76,共7页 Journal of Donghua University(Natural Science)
关键词 1 2 3 4-四氢-1-萘胺 氧化 还原 顺式构型 光学纯 1, 2, 3, 4 - tetrahydronaphthalen - 1 - amine oxidation reduction cis-configuration optically pure
  • 相关文献

参考文献10

  • 1STROBAEK D, HOUGAARD C. Inhibitory gating modulation of small conductance Ca2+ -activated K+ channels by the synthetic compound NS 8593 reduces 1AHP in hippocampal CAI neurons[J] MolPharmacol, 2006, 70(5):1771-1782.
  • 2CKUN F M, LIU X P. In vivo toxicity and pharmacokinetic features of the Janus kinasa 3 inhibitor WHI-pl31 :4-(4'- hydroxyphenyl)- amino - 6,7 - dimcthoxyquinaznline[J]. Clin Cancer Res, 1999, 5(10) :2954-2962.
  • 3MAI.AVIYA R, CHEN C I., NAVARA C, et al, Treatment of allergic asthma by targeting Janus kinase 3- dependent leukotriene synthesis in mast cells with 4-(3', 5' dibromo-4'- hydroxyphenyl) amino - 6, 7 - dimethoxyquinazoline ( WHI p97)[J]. J Pharmacol ExpTher, 2000, 295(3):912 926.
  • 4何新华,郑志兵,李松.酪氨酸激酶Jak3抑制剂的研究进展[J].中国药物化学杂志,2005,15(6):373-377. 被引量:2
  • 5SUDBECK E A, LIU X P, NARLA R K, et al. Structure based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents[J]. Clin Cancer Res, 1999, 5(6):1569-1582.
  • 6WlI.LIAM M T. Process for preparing sertraline: USA, WO9301162[P]. 1993-01-21.
  • 7ROGER A S, ROBERT L W. Stereoisomers of allenic amines as inactivators of monoamine oxidase type B stereochemical probes of the active site[J]. J MedChem, 1988, 31(8) :1558 1566.
  • 8STEFAN G K, CHARLES P V. A facile deprotection of secondary acetamides[J]. Org I.ett, 2009, 11(2) :433 436.
  • 9URAY G, KI.E1DERNIGG O P, MAIER N M, et al. Diphenylethanediamine ( DPEDA ) derivatives as chiral selectors : IV A compai'ison of 3,5 - dinitrobenzoylated ( S, S) - and (S, R)- DPEDA derived chiral stationary phases with Pirkle's standard (R)-phenylglycine derived phase in normal phase HPLCLJ]. Chirality, 1994, 6(2) :116-128.
  • 10OHLMEYER M J. Purine and imidazopyridine derivatives for immunosuppression:USA, US20080287468Al[P]. 2008-11-20.

二级参考文献37

  • 1Gazita, Yalsh P, Gilon C, et al. Tyrphostins Ⅰ: synthesis and biological activity of protein tyrosine kinase inhibitors[ J ]. J Med Chem, 1989, 32 (10) : 2344 -2352.
  • 2Kleinberger-Doron N, Shelah N, Capone R, et al. Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase[J]. Exp Cell Res, 1998, 241(2) :340 - 351.
  • 3Kirken RA, Erwin RA, Taub D, et al. Tyrphostin AG-490 inhibits cytokine-mediated Jak3/Stat 5a/b signal transduction and cellular proliferation of antigen-activated human T cells[J].J Leukoc Biol, 1999,65(6) :891 - 899.
  • 4Behbod F, Erwin-Cohen RA, Wang ME, et al. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts [ J ]. J Immunol,2001, 166(6) :3724 - 3732.
  • 5Stepowski SM, Erwin-Cohen RA, Behbod F, et al.Selective inhibitor of Janus tyrosine kinase 3,PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with raparnycin[J]. Blood, 2002, 99(2) :680 - 689.
  • 6Azuma T, Watanabe N, Yagisawa H, et al. Induction of apoptosis of activated murine splenic T cells by cycloprodigiosin hydrochloride, a novel[J].Immunopharmacology, 2000,46(1):29-37.
  • 7Tsuji RF, Magae J, Yamashka M, et al. Immunomodulating properties of prodigiosin 25-C, an antibiotic which preferentially suppresses induction of cytotoxic T cells[J].J Antibiot, 1992, 45(8) : 1295 - 1302.
  • 8Magae J, Miller MW, Nagai K, et al. Effect of metacycloprodigiosin, an inhibitor of killer T cells, on murine skin and heart transplants [J]. J Antibiot,1996, 49(1) :86 - 90.
  • 9Stepkowski S, Furian L, Janczewska S, et al. Janus tyrosine kinase (Jak3)inhibitor, NC1153, induces apoptosis of T cells and donor-specific transplantation tolerance[ J ]. Am J Transplant, 2004, 4 ( Suppl 8 ) :185.
  • 10Behbod F, Erwin-Cohen RA, Wang ME, et al. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts [ J ]. J Immunol,2001,166(6) :3724 - 3732.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部